Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
NEW YORK, April 02, 2026 (GLOBE NEWSWIRE) -- Roadzen Inc. (Nasdaq: RDZN), a global leader in AI at the convergence of insurance and mobility, today announced that it will present at the upcoming...
-
MLPerf Inference v6.0: the most significant benchmark update ever, with new tests for LLMs, text-to-video, recommenders, and edge AI from 24 submitters.
-
London, United Kingdom , April 01, 2026 (GLOBE NEWSWIRE) -- In 2026, the global landscape continues to evolve. The digitalization of global capital markets and the rapid innovation of financial...
-
Axe Compute to Report Fiscal Year 2025 Financial Results and File Annual Report on Form 10-KConference call and webcast scheduled for April 1, 2026 PITTSBURGH, Pa., March 27, 2026 (GLOBE NEWSWIRE)...
-
BURLINGAME, Calif., March 25, 2026 (GLOBE NEWSWIRE) -- Roadzen Inc. (Nasdaq: RDZN), a global leader in AI at the convergence of insurance and mobility, today announced that drivebuddyAI, its driver...
-
Kognitos recognized as an Exemplary Provider in the 2026 ISG Buyers Guide™ for Automation and Orchestration Emerging Providers, published by ISG Research.
-
REDMOND, Wash., March 23, 2026 (GLOBE NEWSWIRE) -- Pattern Computer®, Inc. (“Pattern” or “the Company”), the global leader in Pattern Discovery, today announced the publication of its latest...
-
REDMOND, Wash., March 18, 2026 (GLOBE NEWSWIRE) -- Pattern Computer®, Inc. (“Pattern” or “the Company”), the global leader in Pattern Discovery, today announced expanded global intellectual property...
-
Resonate and New Blue Interactive win the Reed Award for Best Use of Analytics/ML in Fundraising: 277% targeting lift, 64% more raised per email.
-
Newly discovered drug leverages the power of Pattern Discovery Engine™ (PDE) and is an extension of 2025 study wherein Pattern developed novel risk assessment tool, discovered new drug target for...